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Net return distributions when metaphylaxis is used to control bovine respiratory
disease in high health-risk cattle
Elliott J. Dennis,*,1 Ted C. Schroeder,† and David G. Renter‡
*Department of Agricultural Economics, University of Nebraska – Lincoln, Lincoln, NE 68583; †Department
of Agricultural Economics, Kansas State University, Manhattan, KS 66506; and ‡Center for Outcomes Research
and Epidemiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506

ABSTRACT: This study’s objective was to estimate net returns and return risk for antimicrobial
metaphylaxis options to manage bovine respiratory disease (BRD) in high health-risk feedlot
cattle. The effectiveness of antimicrobials for
metaphylaxis varies by cattle population. How
differing antimicrobial effectiveness translates to
net return profitability for heterogeneous cattle
populations is less understood. Net returns and
return risk were assessed using a net return simulation model adapted to allow for heterogeneity
in high health-risk cattle placement characteristics
and antimicrobial choice to control BRD. The net
return model incorporated how antimicrobials
modify BRD health and performance outcomes.
Health and performance outcomes were calibrated
from published literature and proprietary feedlot
data. Proprietary data came from 10 Midwestern
feedlots representing nearly 6 million animals and
50,000 cohorts. Twelve placement-by-metaphylaxis
decision combinations were assessed: high healthrisk steer placement demographics were 600 or 800
lb steers placed in Winter (Oct–Mar) or Summer
(Apr–Sept) managed with one of three different
health programs: “no metaphylaxis,” “Upper Tier”
antimicrobial, or “Lower Tier” antimicrobial. Net

return distributions were compared between “no
metaphylaxis” and a specific antimicrobial tier
within specific cattle populations. We found the
expected incremental net return of administering
an “Upper Tier” (“Lower Tier”) antimicrobial
for metaphylaxis compared to “no metaphylaxis”
for high health-risk steers was $122.55 per head
($65.72) for 600 lb and $148.65 per head ($79.65)
for 800 lb winter placements. The incremental
expected net return and risk mitigated by metaphylaxis varied by placement weight, season, and
antimicrobial choice. The probability net returns
would decline by at least $50 per head was significantly reduced (from approximately 4% to 40%)
when any antimicrobial was used on high healthrisk steers. Both tiers of antimicrobials used for
metaphylaxis increased expected net returns and
decreased net return variability relative to no metaphylaxis. Thus, feedlots were more certain and
realize a greater profit on high health-risk pens of
steers when metaphylaxis was used. This occurred
because the reduction in cattle health and performance outcomes using any antimicrobial was sufficiently large to cover added initial and subsequent
antimicrobial costs. Results aid in assessing metaphylaxis strategies in high health-risk cattle.
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INTRODUCTION
Antimicrobials used to improve the well-being,
health, and performance of cattle arriving at feedlots have received considerable public attention.
Metaphylaxis, administration of an antimicrobial,
generally via injection, is used by 39% of U.S. feedlots with 1000+ head capacity selectively on 17%
of cattle to reduce adverse effects of bovine respiratory disease (BRD) in high health-risk cattle
(United States Department of Agriculture, 2019).
Randomized control trials have generally confirmed
metaphylaxis can reduce morbidity and mortality
in feedlot cattle where health-risk susceptibility is
high (O’Connor et al., 2013; Abell et al., 2017).
Categorization as high health risk generally refers
to cattle with one or more risk factors for BRD,
which may include unknown health history, recent
weaning, and various source and transport stressors (Nickell and White, 2010; Ives and Richeson,
2015; Smith et al., 2017).
When cohorts of cattle arrive at feedlots, feedlots assess animal health risks and decide whether
to manage cattle with metaphylaxis. Perceived
benefits of metaphylaxis for reducing cattle morbidity and mortality are weighed against costs
to process, treat, and monitor cattle during their
time on feed. If metaphylaxis is elected, feedlots
must select the type of antimicrobial to administer (Nickell and White, 2010). The selection of
the specific antimicrobial to use is primarily based
on veterinary consultation, past experience, and
duration of action (United States Department of
Agriculture, 2013). While the effectiveness and cost
of antimicrobials used for metaphylaxis vary, how
these differences translate into expected net return
distributions for heterogeneous cattle has not been
described (DeDonder and Apley, 2015; Ives and
Richeson, 2015).
Realized cattle morbidity and mortality conditional on antimicrobial choice and administration
are unknown until after cattle harvest. As such,
animal health outcomes are uncertain when the
metaphylaxis decision is made. Stochastic net return simulations have been used to value BRD for
dairy, cow-calf, and feedlot cattle (Van der FelsKlerx et al., 2001; Buhman et al., 2003; Nor et al.,
2012; Theurer et al., 2015; Wang et al., 2018) and to
value animal health protocols such as metaphylaxis
in feedlot cattle (Dennis et al., 2018). Stochastic
simulations are distinctly different than deterministic simulations because they incorporate uncertainty via probability distributions obtained from
historical data, expert opinion, and/or published

literature. However, no studies have examined how
net returns differ by the type of antimicrobial used
for metaphylaxis across different cattle placement
demographics.
The objective of this study is to measure net
return and return risk between “Upper Tier” and
“Lower Tier” antimicrobials used for metaphylaxis
and a “no metaphylaxis” option in high health-risk
feedlot cattle. In particular, we test whether expected net return distributions vary across cattle
placement weight, placement season, and antimicrobial tier administered.
MATERIALS AND METHODS
Cattle feeding net returns vary across management, marketing, and animal health protocols.
Cattle feeding net return distributions are estimated using a variation of the stochastic simulation model developed by Dennis et al. (2018). The
primary purpose of Dennis et al. (2018) was to estimate the economic value of metaphylaxis to the
U.S. fed cattle industry. This economic value was
then used to determine how removing metaphylaxis as an animal health protocol would impact
feedlots, processors, and consumers. In order to
calculate the overall industry-level impact of metaphylaxis, the authors used an “average” animal
gender, placement season, and antimicrobial used.
We modify their simulation method by allowing
placement season, weight, and antimicrobial
used for metaphylaxis to vary. In what follows, we
briefly describe the cattle feeding economic decision framework used in our stochastic simulation
emphasizing how we incorporate heterogeneity
into the Dennis et al. (2018) cattle feeding net return simulation model.
Cattle Feeding Net Return Stochastic Simulation
We consider four types of high health-risk
steers purchased by feedlots—two cattle placement weights (600 or 800 lb) and two placement
seasons (Oct–Mar referred to as “Winter” or Apr–
Sept referred to as “Summer”). In our simulation,
we considered three different health management
options for high health-risk steers: “no metaphylaxis,” “Upper Tier” antimicrobial, or “Lower Tier”
antimicrobial. High health-risk cattle are cattle that
are classified to be at-risk for BRD and should be
managed with metaphylaxis. Antimicrobials were
categorized into “Upper” and “Lower” tiers based
on categorizations from the work of Abell et al.
(2017) where they classified antimicrobials into
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tiers conditional on odds ratio (OR) confidence
intervals for different morbidity and mortality
outcomes. Thus, our simulation compared eight
different metaphylaxis scenarios (one gender, two
placement weights, two seasons, and two tiers of
antimicrobials used for metaphylaxis) to four “no
metaphylaxis” scenarios (one gender, two placement weights, two seasons).
Regardless of initial health status and health
management strategy, cattle can become sick and/
or die. Feedlots realize final morbidity and mortality only at cattle harvest. In our model, all cattle,
regardless of initial health-risk status, possessing
clinical signs of BRD are pulled and treated. Sick
cattle incur greater health costs (HC ↑), gain less
weight per day during feeding (ADG ↓), and require more feed to gain an additional pound of
weight (AFC ↑) (Tennant et al., 2014). Feedlots do
not sell dead animals (CSW = 0) losing the initial cost of the feeder (FDRC) plus any cost for
yardage (YC ≥ 0), feed (FC ≥ 0), interest (IC ≥ 0),
and health treatments (HC ≥ 0). Morbidity and
mortality combine to increase total feeding costs
(TC ↑) effectively decreasing profit (π ↓). Mortality
poses a high cost to feedlots and is the primary
driver of net return and return risk in our stochastic simulation.
After initial processing, cattle that survive and
reach an expected harvest weight are sold on a
live-weight basis. Thus, feedlots choose the type of
cattle to purchase, initial and supplemental health
protocols, and cattle target finish weight. Given
this, cattle feeding net returns (π) per head for a
given cohort of cattle can be specified as (Dennis
et al., 2018):
TR


π =

Total revenue

− FDRC − YC − FC − HC − IC



Total costs

(1)

TR


Total revenue

×{

= 
FP

×
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Finshed weight

(1 − SHRINK)




Transportation weight loss

Fed Price

× (1 − MORT − ICLL) } )



Lbs. of animals solds
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=
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(3)

YC
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0.30
×
DOF

  
(4)
Yardage costs
Fixed Rate
Days on feed
×{

FC = FEED
  


Feed costs

Price of corn

×



AFC



[CSW × (1 − MORT − CULL) − CPW ] }



Total weight gain while at feedlot


Feed conversion





Total amount of feed consumed while at feedlot

(5)
IC


Interest costs

= {0.5 × [YC + FC + HC] +FDRC}



Entire feeder and half of all other costs

× (IR/365)
  
Interest rate

×

DOF


Days on feed

(6)
Table 1 describes each variable in detail.
Our objective was to determine how net return
distributions change for high health-risk cattle as
feedlots use different antimicrobial tiers across different placement weights and seasons. To do this,
we calibrated the expected return in the simulation
models by using breakeven (π = 0) feeder cattle
purchase prices for the “Upper Tier” antimicrobial
used for each season and placement weight. This
enabled us to compare net return distributions with
and without metaphylaxis and across tiers of antimicrobials used for metaphylaxis but only within its
respective season and placement weight not across
different seasons or placement weights.
Data
Ten large commercial feedlot operations located in several Midwestern states provided two
animal health and performance data sets used in
this study. Cohorts are the common aggregate unit
in commercial feedlot production systems. Cohortlevel animal health treatment information is the
primary difference between the two data sets. We
define cohorts (lots or pens) as animals purchased,
assembled, and managed as an observable unit.
When finished cattle are marketed, closeouts records record cohort-level animal performance and
health information.
Observational data used in this study included
a large panel data set comprising 48,341 cohorts of
cattle (about 6 million head) placed on feed during 1989–2008. This data set consisted of typical
closeout information including HCs after feeding
began excluding costs of metaphylaxis. These data
were used to calibrate animal feeding performance
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Table 1. Feeding net return variables
Variables
Simulated
ADG
AFC
DOF
FC
HC
IC
MORT
TR
YC
π
Fixed
CPW
CSW
CULL
CULLP
CULLW
FDRC
FEED
FP
FRP
IR
SHRINK

Description

Value/Calculation

Average daily gain during feeding (lb/head/day)
Average pounds of feed consumed per pound of weight gain (lb feed/lb gain)
Number of days on feed (days)
Feed cost ($/head)
Animal health care cost including metaphylaxis, pull-and-treat, vaccinations,
labor costs, etc. ($/head)
Interest cost ($/head)
Proportion of mortality in purchased group
Total revenue from cattle sales ($/head)
Yardage cost of feeding cattle ($/head)
Net feeding returns ($/head)

See Table 3
See Table 3

Cattle purchase weight (lb/head)
Finished animal weight (lb/head) if animal reaches maturity
Proportion chronically ill animals culled from the remaining cohort
Price received for culled animals ($/lb)
Average weight of culled animals (lb/head)
Feeder cattle purchase cost ($/head)
Corn price when cattle are placed on feed ($/lb)
Fed cattle sale price ($/lb)
Purchase price for CPW 600 (spring, winter) 800(spring, winter) lb ($/lb)

600, 800
1,350
0.0140
0.75 × FP
861
See Eq. 3
0.0923
1.48
2.1461, 2.1379,
1.7591, 1.7436
0.05
0.04

Annualized interest rate
Proportion shrink in live weight when marketed

over time (i.e., ADG and AFC), which varied by
season, location, and animal weight. The second
observational data used comprised 1,357 cohorts
of cattle (about 264,000 head) placed on feed during 2014–2015. This more detailed, but smaller data
set, documented both cohort and individual animal
antimicrobial treatments associated with BRD enabling us to estimate the cost of metaphylaxis and
facilitated our stochastic simulation around cattle
mortality. Table 2 displays summary statistics for
the feedlot data.
Cattle Morbidity and Mortality
Metaphylaxis is expected to reduce morbidity
and mortality in high health-risk feedlot cattle, but
expected effectiveness varies by cattle placement
weight, placement season, gender, and antimicrobial used (Nickell and White, 2010; DeDonder
and Apley, 2015; Ives and Richeson, 2015). In our
model, the impact of metaphylaxis on morbidity is
reflected by its effects on three cattle performance
parameters—average daily gain (ADG), average
feed conversion (AFC), and HCs.
Multivariate Tobit, ordinary least squares, maximum likelihood, and linear mixed models (LMMs)
have been used to model variation in ADG,

See Eq. 5
See Table 3
See Eq. 6
See Figure 1
See Eq. 2
See Eq. 4
See Eq. 1

veterinary/medication costs, and feed conversion in
cattle across seasons, placement weights, etc. (Miller
et al., 2005; Irsik et al., 2006; Belasco, 2008; Belasco
et al., 2009; Dennis et al., 2018). In our study, cattle performance parameters were quantified using
an LMM with cohort size (i.e., the number of head
per lot), year, and feedlot specific random effects to
account for the hierarchical nature of cattle feeding data where cohorts of cattle are nested within
feedlots. Fixed effects for the estimation of ADG
and AFC included the percentage of cohort level
mortality (MORT × 100), the natural log of cattle placement weight (lnCPW), whether the cohort
were steers (STEER), and whether cattle were
placed between October and March (WINTER).
Cohort-level HCs are estimated in a similar format to ADG and AFC but WINTER is omitted
because of the short time horizon of the data. In
addition, binary variables indicating the antimicrobial tier given for metaphylaxis to a cohort are
included (UPPER TIER or LOWER TIER). We
estimated ADG and AFC equations using the large
panel data set and associated HC using the more
recent detailed data set.
We conditioned cattle mortality on cattle placement weight, placement season, and antimicrobial
used for metaphylaxis. Mortality distributions are
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Table 2. Feedlot performance summary characteristics for two periods
January 1989–December 2008a
Feed conversion (lb feed/lb gain)
Average daily gain (lb gain/day)
Mortality (%, MORT ×100)
Placement weight (lb)
Days on feed (days)
Gender
Season
August 2014–December 2015b
Feed conversion (lb feed/lb gain)
Average daily gain (lb gain/day)
Mortality (%)
Placement weight (lb)
Days on feed (days)
Gender
Season

Mean

SD

Min

Max

6.07
2.96
1.24
683.7
154.5
Steer
Spring
Fall

0.59
0.56
1.76
128.99
44.17
45.7%
25.1%
24.3%

3.01
1.51
0.00
304.20
128.00
Heifer
Summer
Winter

9.91
5.98
25.64
1,100.00
229.00
54.3%
27.4%
23.2%

6.16
3.24
2.52
700.8
192.8
Steer
Spring
Fall

0.58
0.49
3.19
177.49
67.20
55.0%
25.8%
25.8%

4.30
1.65
0.00
301.00
87.00
Heifer
Summer
Winter

8.76
5.18
26.78
1096.00
443.30
45.0%
23.2%
25.2%

Period one has 48,341 cohorts/pen.
Period two has 1,357 cohorts/pen.
Source: Proprietary feedlot data.
a

b

known to be right-skewed with long tails, approximated using a log-normal, (zero-inflated) negative
binomial or a (zero-inflated) Poisson distribution
(Babcock, 2010). We modeled all mortality distributions as log-normal. Mortality distributions for
the “Upper Tier” and “Lower Tier” antimicrobials
were fit using the mean and standard deviation of
mortality observed from proprietary production
level data. However, the mortality of high healthrisk cattle not managed with metaphylaxis was not
observed in feedlot data because feedlots give metaphylaxis to all cattle categorized as high health
risk upon arrival. Thus, mortality distributions for
high health-risk cattle not treated with metaphylaxis were approximated using ORs from a mixed
treatment comparison (MTC) meta-analysis (Abell
et al., 2017). An MTC meta-analysis summarizes
published randomized control antimicrobial trials for BRD-related cattle morbidity and mortality and can be used to assess indirect comparisons
across different antimicrobials used for metaphylaxis (O’Connor et al., 2013; Abell et al., 2017).
Differences Across Antimicrobials Used for
Metaphylaxis
One important concern is the endogenous producer choice to match the type of antimicrobial
used for metaphylaxis to different cattle populations. The potential endogenous decision implies

that simply comparing mortality outcomes in observational data between two different antimicrobial
tiers is incorrect. Even after statistically matching
cattle that received different tiers of antimicrobials
based on observable feedlot and pen characteristics, the antimicrobial choice is still nonrandom.
Thus, in this context, traditional quasi-experimental methods to ascertain causality are insufficient.
We solve this issue by developing a counterfactual
mortality distribution that answers the following
question: “Given we observe the mortality rate for
a ‘Lower Tier’ antimicrobial, what would have been
the observed mortality on that same cohort of cattle had an ‘Upper Tier’ antimicrobial been used?”
To answer this proposed counterfactual question, we first multiplied the estimated OR (0.62) for
Tilmicosin (the “Lower Tier” antimicrobial) from the
work of Abell et al. (2017) by a proposed hypothetical “no metaphylaxis” mortality rate. This resulted
in a hypothetical proposed “Lower Tier” antimicrobial mortality rate. We then iterated through different
hypothetical proposed “no metaphylaxis” mortality
values until the hypothetical proposed “Lower Tier”
mortality rate matched the rate observed in the more
recent intensive data. Then, the corresponding “Upper
Tier” antimicrobial mortality was obtained by multiplying the resulting “no metaphylaxis” mortality rate
by the estimated OR (0.16) for Tulathromycin (the
“Upper Tier” antimicrobial) from the work of Abell
et al. (2017). Our proposed method is loosely similar

Translate basic science to industry innovation

1096

Dennis et al.

to the Bayesian method used by Abell et al. (2017) to
obtain differences in ORs for different types of antimicrobials. Comparing the ORs obtained using our
proposed method and those obtained by Abell et al.
(2017) and find that they are not statistically different
from each other. Thus, we applied our procedure for
each of the four different placement weight by placement season scenarios: 600 lb summer, 600 lb winter,
800 lb summer, and 800 lb winter. Thus, by using this
procedure resulting mortality rates, and subsequent
net return distributions, could be compared within
season and placement weights. The code for this optimization method can be obtained by contacting the
authors.
Simulation to Obtain Net Return Distributions
Our simulation method closely follows the
method proposed by Dennis et al. (2018) to obtain
net returns. We briefly describe those methods here
and a more complete and detailed description can be
found in the work of Dennis et al. (2018). The simulation method is as follows. First, we specified the
high health-risk steer placement weight and placement season. Second, we selected what antimicrobial
tier was given, if any. Third, given these choices, we
randomly selected a mortality rate from the corresponding mortality distribution. Fourth, the steer
placement, metaphylaxis decision, and random mortality draw were multiplied by estimated beta coefficients from the LMM. Fifth, these stochastic ADG,
AFC, and HC were used to calculate cattle feeding net
return profit (π) from Eq. 1 for one cohort of cattle.
Net return distributions for the 12 different scenarios

(one gender, two placement weights, two placement
seasons, three metaphylaxis options) were generated
by repeating steps 1 to 5 using 5,000 Halton draws.
RESULTS
Descriptive Statistics
On average (min, max) cattle were placed at approximately 700 lb, gained 3 lb per day (1.5, 6.0),
and had feed conversion of about 6 (3.0, 9.9) over
155 days on feed (128, 229). Cattle were placed
evenly across seasons. The average mortality for
period one cattle was 1.24% (0.0, 25.6). A large
variation in mortality in both time periods was due
to initial health status (high vs. low health risk),
differing cattle populations (light vs. heavy weight),
and placement season (winter vs. summer).
Estimated Morbidity
Table 3 displays parameter estimates for the
estimated ADG, AFC, and HC models. Increased
mortality was associated with lower daily gains
(ADG ↓), increased feed conversion (AFC ↑), and
increased HCs (HC ↑). Higher placement weights
were associated with higher feed conversions (AFC
↑) and higher daily gains (ADG ↓). Placement weight
was excluded from the HCs equation. Cattle placed
during winter months had marginally higher daily
gain and higher feed conversion. If an “Upper Tier”
(“Lower Tier”) antimicrobial was used for metaphylaxis, feedlots incurred an estimated $28.61 ($23.97)
per head cost for administration. Company random

Table 3. LMM estimation for cattle performance that serves as a proxy for cattle morbidity
ADG
Fixed effects
Constant
Mortality (MORT × 100)
Log placement weight (lnCPW)
Steer (STEER)
Oct–Mar (WINTER)
Antimicrobial (Upper Tier)
Antimicrobial (Lower Tier)
Random effectsb
Company
Cohort size
Placement year
Observations
REML convergence

–4.536 (0.10)a
–0.059 (0.00)
1.147 (0.01)
0.238 (0.00)
0.009 (0.00)

AFC

HC

–1.129 (0.14)
0.050 (0.00)
1.144 (0.02)
–0.272 (0.01)
0.004 (0.01)

5.936 (7.80)
1.541 (0.80)
1.782 (0.42)
28.605 (0.85)
23.969 (0.84)

0.016
0.002
0.007
48,341
41,678

0.016
0.003
0.072
48,341
75,791

Numbers in parenthesis () are standard errors.
Variances are reported for each random effect.
Source: Author’s calculations.
a

b
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effects suggested significant variation in company
animal HCs.
Mortality Distributions
Figure 1 displays log-normal mortality distributions for high health-risk steers conditional on
placement weight, season, and antimicrobial used
for metaphylaxis. Both tiers of antimicrobials used
for metaphylaxis reduced expected mortality and
the associated variance. Table 4 displays the parameters used to calculate the log-normal mortality distributions. Winter placements, across both weights,
had larger mortality mean and variances. “Upper

Tier” antimicrobials on average reduced mortality by more than “Lower Tier” antimicrobials and
narrowed the associated variance. Not treating
with metaphylaxis resulted in larger average mortality and greater variation across all seasons and
placement weights for high health-risk steers not
managed with metaphylaxis. Thus, metaphylaxis
reduced mortality in high health-risk steers but varied by a class of antimicrobial used.
Net Return Distributions
Figure 2 displays net return distributions by
cattle placement weight and season across three

Figure 1. Mortality distributions for high health-risk steers by placement weight, placement season, and type of antimicrobial used for metaphylaxis. Antimicrobials used for metaphylaxis are categorized into “Upper” and “Lower” tiers based on Abell et al. (2017) who categorized them
based on odds ratio (OR) confidence intervals.
Source: Abell et al. (2017) and author’s calculations.

Table 4. Mortality distributional assumptions for cattle type and antimicrobial treatment
Antimicrobial
Upper Tier
Upper Tier
Upper Tier
Upper Tier
Lower Tier
Lower Tier
Lower Tier
Lower Tier
No Metaphylaxis
No Metaphylaxis
No Metaphylaxis
No Metaphylaxis

Placement weight (lb)
600
600
800
800
600
600
800
800
600
600
800
800

Season
Summer
Winter
Summer
Winter
Summer
Winter
Summer
Winter
Summer
Winter
Summer
Winter

Meana (%)
1.07
1.36
0.94
1.57
4.14
5.26
3.66
6.10
6.68
8.49
5.90
9.83

SDa (%)
0.91
1.23
0.55
0.54
3.77
5.08
2.30
2.24
6.49
8.75
3.96
3.87

a
To account for endogenous producer decisions in using specific antimicrobials on specific cattle populations we use the odds ratios from Abell
et al. (2017) for the lower tier antimicrobial and the mortality observed in lower tier antimicrobials to solve for the mortality of the control. We then
use this control mortality and the odds ratios for the upper tier antimicrobial to obtain the mortality for the upper tier antimicrobial. This allows
us to obtain the mortality of different antimicrobials on different cattle populations. A similar producer was used to find the standard deviations.
In some cases, due to the absence of sufficient observations of steer pens (i.e., n ≥ 20), a pooled steer and heifer estimate was used.
Source: Proprietary feedlot data and Abell et al. (2017).
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animal health management decisions: “no metaphylaxis,” “Upper Tier” antimicrobial, and
“Lower Tier” antimicrobial. “No metaphylaxis”
net return distributions represent high healthrisk steer cohorts not managed with metaphylaxis upon arrival. The differences in expected
net returns per head (averages) between administering an “Upper Tier” (“Lower Tier”) to “no
metaphylaxis” were 1) $96.08 ($50.39) for 600 lb
summer placements, 2) $122.55 ($65.72) for 600
lb winter placements, 3) $90.36 ($51.14) for 800 lb
summer placements, and 4) $148.65 ($49.65) for
800 lb winter placements. The difference between
the Upper Tier and Lower Tier is the marginal
net benefit of using a certain antimicrobial tier for

metaphylaxis. For example, the value of administering an “Upper Tier” compared to a “Lower
Tier” for 600 lb summer placements is $45.69
(96.08−50.39 = 45.69). On average, “Upper Tier”
antimicrobials were valued at $52.69 compared to
“Lower Tier” antimicrobials across all placement
weights and seasons.
Both antimicrobials used for metaphylaxis
increased expected net returns and decreased net
return variation. In other words, cattle feedlots
were more certain that they will realize greater profits on a cohort of high health-risk cattle when any
tier of antimicrobial was used for metaphylaxis.
Table 5 further summarizes the net return distributions displayed in Figure 2 reporting percentages of

Figure 2. Net return distributions for high health-risk steers by placement weight, placement season, and type of antimicrobial used for metaphylaxis. Data used to generate the distributions are obtained from the simulation described in the main body of the text.
Source: Author’s calculations.

Table 5. Percentages of steer cohorts within net return ($/head) categoriesa
600 lb Placement weight
Summer (Apr–Sept)
Net returns ($/head)
Metaphylaxis
(-∞,-252)
(-251, -51)
(-50, 0)
(0, 50)
(>51)
No metaphylaxis
(-∞,-252)
(-251, -51)
(-50, 0)
(0, 50)
(51, +∞)

800 lb Placement weight

Winter (Oct–Mar)

Spring (Apr–Sept)

Winter (Oct–Mar)

Upper

Lower

Upper

Lower

Upper

Lower

Upper

Lower

0.00
1.64
34.12
64.24
0.00

1.64
37.56
40.56
20.24
0.00

0.00
3.64
34.44
61.92
0.00

4.40
40.32
33.12
22.16
0.00

0.00
0.08
41.68
58.24
0.00

0.04
41.72
51.68
6.56
0.00

0.00
0.00
47.80
52.20
0.00

0.04
76.64
23.00
0.32
0.00

7.08
35.64
24.24
33.04
0.00

7.08
35.64
24.24
33.04
0.00

12.56
34.56
21.00
28.16
3.72

12.56
34.56
21.00
28.16
3.72

2.16
44.04
34.12
19.68
0.00

2.16
44.04
34.12
19.68
0.00

4.68
79.68
14.56
1.08
0.00

4.68
79.68
14.56
1.08
0.00

a
Antimicrobials used for metaphylaxis are categorized into “upper” and “lower” tiers based on Abell et al. (2017) who categorized them based
on odds ratio (OR) confidence intervals.
Source: Author’s calculations.
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the 5,000 simulated cohorts falling within expected
net return ranges conditional on cattle placement
weight, placement season, and antimicrobial used.
Metaphylaxis administered to high healthrisk cattle substantially reduced the probability
of large losses. For example, for a cohort of 600
lb summer placed high health-risk steers treated
with an “Upper Tier” antimicrobial, there was
a 1.64% (0.00% + 1.64%) chance of realizing a
loss of more than $50 per head; 0.00% probability
of losses less than −$251 per head; 1.64% probability of losses between −$51 and −$251. If high
health-risk steers were not treated, they faced a
42.72% (7.08% + 35.64%) probability of losing
more than $50 per head. For a cohort of 600
lb high health-risk winter placed steers treated
with a “Lower Tier” they faced a 44.72% (4.40%
+ 40.32%) chance of realizing at least a $50 per
head loss. Not treating this same cohort resulted
in a 47.12% (12.56% + 34.56%) probability of
realizing at least a $50 per head loss. Taking this
result further, large losses in excess of $250 per
head had a 7% to 12% probability of being realized for high health-risk 600 lb placed steers not
treated with any antimicrobial compared to generally less than 0% to 4% probability of such large
losses regardless of season or antimicrobial tier
used for metaphylaxis.
Heavier weight placements were less likely to
have large negative returns since the proportion of
cattle that died was relatively small compared to
lighter placements. For example, a cohort of 600
lb summer placed high health-risk steers administered an “Upper Tier” antimicrobial faced a 1.64%
(0.00% + 1.64%) chance of realizing a loss greater
than $50 per head compared to 0.08% (0.00% +
0.08%) for a cohort of 800 lb steers placed at the
same time and administered the same tier of antimicrobial. Summer placed high health-risk steers
were expected to have a lower risk of large losses
compared to winter placements. For example, a
cohort of 800 lb summer placed high health-risk
steers treated with a “Lower Tier” antimicrobial
had a 41.76% (0.04% + 41.72%) probability of realizing a loss of more than $50 per head compared
to 76.68% (0.04% + 76.64%) for the same cohort
placed in winter.
DISCUSSION
The objective of this study was to estimate net
return and return risk between “Upper Tier” and
“Lower Tier” antimicrobials used for metaphylaxis
to manage BRD and a “no metaphylaxis” option in
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high health-risk feedlot cattle. We used a stochastic
net return simulation model to determine how net
return and return risk varied across cattle populations placed in different seasons and given different
tiers of antimicrobials. As such, the outcomes are
broad enough to encompass a variety of situations
relevant to the feedlot industry.
The decision of whether to manage high healthrisk cattle with metaphylaxis, and if so, which tier
of antimicrobial to use, is a difficult question to answer in part because the decisions are made with
incomplete information. Realized health outcomes
are only known after cattle have finished feeding
whereas metaphylaxis decisions are generally made
at the time of cattle placement. Thus, we must rely
on expected return distributions with and without
the use of metaphylaxis to assess their expected
economic value.
Metaphylaxis modifies cattle morbidity and
mortality (Nickell and White, 2010; Tennant
et al., 2014). In our model morbidity impacts
were reflected through the decrease in cattle performance parameters (ADG, AFC, and HCs).
Higher placement weights were associated with
higher ADG and higher AFC consistent with randomized control trials that as placement weight
increases so does AFC (Nickell and White, 2010).
Positive correlations between HC and mortality
are consistent with both trial and production-level
data as both are associated with the rate at which
feedlots are pulling and treating cattle. Estimated
lower cattle performance in winter months is
consistent with literature demonstrating cattle
devote more energy to body temperature maintenance during colder months (Mader et al., 2010).
“Upper Tier” antimicrobials are more expensive
consistent with price premiums for a perceived
higher quality product. Both antimicrobial tier
cost estimates are generally consistent with results
from the National Animal Health Monitoring
Survey that reported average antimicrobial costs
of $23.50 per head to administer metaphylaxis
to feeder cattle (United States Department of
Agriculture, 2013).
Mortality distributions were estimated as
log-normal and fit using the mean and standard
deviation of mortality for the different tiers of antimicrobials used for metaphylaxis and a “no metaphylaxis” option. Metaphylaxis modifies both the
mean and standard deviation of mortality distributions consistent with previous literature (Dennis
et al., 2018). Results also align with the knowledge
that heavier cattle and summer placed cattle have
lower mean mortality with less variation (Babcock
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et al., 2009). “Upper Tier” antimicrobials reduced
both the variation and mean mortality values across
all placement weights and placement seasons (Abell
et al., 2017). Likewise, feedlots opting to use a “no
metaphylaxis” option on high health-risk cattle significantly increases variation and mean mortality
consistent with the idea that using any antimicrobial on high health-risk cattle is beneficial (Nickell
and White, 2010).
An interesting result relative to the decision to
manage high health-risk steer cohorts with metaphylaxis is that high net returns (low mortality) can
still, by chance, be realized whether or not cattle are
managed with metaphylaxis. For example, for 600
lb high risk steers placed, regardless of season or
antimicrobial administered for metaphylaxis would
expect more than 35% of the time to realize positive net returns. However, there is still at least a
20% chance that a high-risk cohort would realize
positive net returns if not administered metaphylaxis. This is because there is a chance that high
health-risk cattle, even if not given metaphylaxis,
will remain sufficiently healthy and not have high
mortality.
Expected return alone is insufficient to assess
the viability of metaphylaxis if return risk also
matters. Treating all high health-risk cattle with
metaphylaxis broadly increases expected net return and reduces return variability. This makes
the use of metaphylaxis as a health management
practice appears obvious. However, the change
in expected return, as well as the risk mitigated
through metaphylaxis of all high-risk cattle, varies
by placement season, tier of antimicrobial used,
and cattle placement weight. Lighter weight high
health-risk cattle are expected to realize greater
returns and more return risk mitigation through
metaphylaxis regardless of the season and antimicrobial tier (of those investigated here), than
heavier weight placements.
The value of meeting production or marketing contract agreements is a value of metaphylaxis
not currently captured in the simulation. Feedlots
can use metaphylaxis as a preventative measure to
help enable them to have enough cattle reach harvest weight to comply with agreements/contracts
with meat packers. Thus, the value of metaphylaxis
represents more than just the loss in input costs as
currently calculated. Thus, estimated values likely
serve as a lower bound to the value of metaphylaxis
for feedlots.
Our simulation had feedlots sell cattle on a live
weight basis and did not allow for any discounts or
premiums for carcass yield and quality grade. Thus,

if carcass quality is affected by the use of metaphylaxis then the net value of metaphylaxis would
change based on premiums and/or discounts for
yield and quality grade.
An important issue, not addressed in this study
but deserves more consideration given our findings,
is how to identify and categorize high health-risk
cattle. The occurrence of respiratory disease in
some cattle in a cohort, BRD problems in cattle previously received from the same source, and known
lack of preconditioning are all important in determining whether a group of cattle should be managed with metaphylaxis (United States Department
of Agriculture, 2019). Feedlots can discount high
health-risk cattle at purchase to offset perceived
production and HCs. High-risk cattle are worthless
to the feedlot than otherwise similar low-risk cattle,
since they can require higher HCs and have greater
morbidity and mortality risk with more variable
net returns. Feedlots that are able to correctly categorize cattle health risk could capitalize on these
discounts.
In practice high health-risk cattle are managed
with metaphylaxis and feedlots do not observe net
return outcomes from high health-risk cattle not
managed with metaphylaxis. While positive profits
can be obtained, feedlots may perceive the realization of major net return losses to be worse than
the potential positive profits from not managing
with metaphylaxis. Likewise, the error associated
with mis-categorization of cattle into health-risk
bins further complicates this decision process. We
expect with the more accurate categorization of
cattle into health-risk status upon feedlot arrival,
health management strategies could be refined.
Of course, the cost of acquiring additional information for more accurate animal health status
classification may exceed the value. For example,
chute-side diagnostics aimed at identifying sick
cattle on arrival may be too costly or time and
labor prohibitive.
The estimates from our study should be held in
the context of the fed and feeder cattle price levels
used. Previous work indicates that changing input
and output price levels can impact the value of metaphylaxis (Dennis et al., 2018) and in our case the
value for each antimicrobial tier. The average fed
cattle price used in this simulation was $148/cwt
(see Table 1). Higher fed cattle prices create greater
value associated with metaphylaxis, all else held
equal. As fed cattle prices increase, the cost of mortality increases. As such, fed cattle price has important impacts on the value of metaphylaxis because
higher fed cattle prices are associated with higher
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feeder cattle prices and any mortality has a greater
economic cost to the feedlot.

1101

disease and mortality in commercial feedlots [PhD diss.].
Manhattan (KS): Kansas State University.
Babcock, A.H., B.J. White, S.S. Dritz, D.U. Thomson, and
D.G. Renter. 2009. Feedlot health and performance
CONCLUSIONS
effects associated with the timing of respiratory disease
treatment. J. Anim. Sci. 87(1):314–327. doi:10.2527/
Results identified the net return and return
jas.2008-1201.
risk of using two different antimicrobial tiers for
Belasco, E.J. 2008. The role of price risk management in mitmetaphylaxis compared to no metaphylaxis, in difigating fed cattle profit exposure. J. Agric. Resour. Econ.
33(3):332–348.
ferent high-risk cattle populations. Likewise, we
Belasco, E.J., M.R. Taylor, B.K. Goodwin, and T.C. Schroeder.
quantified the relative benefit of using an “Upper
2009. Probabilistic models of yield, price, and reveTier” antimicrobial compared to a “Lower Tier”
nue risks for fed cattle production. J. Agric. App. Econ.
antimicrobial for metaphylaxis. “Upper Tier” anti41(1):91–105. doi:10.1017/S1074070800002571.
microbial produced higher net returns and lower reBuhman, M.J., L.L. Hungerford, and D.R. Smith. 2003. An
turn risk compared to “Lower Tier” antimicrobials.
economic risk assessment of the management of pregnant feedlot heifers in the USA. Prev. Vet. Med. 59:
Both antimicrobial tiers were valued more than not
207–222. doi:10.1016/S0167-5877(03)00104-1.
administering metaphylaxis, but this expected value
DeDonder, K.D. and M.D. Apley. 2015. A review of the
varies by cattle placement season and placement
expected effects of antimicrobials in bovine respiraweight. Further research is needed to determine
tory disease treatment and control using outcomes from
how feedlots substitute between these tiers of antipublished randomized clinical trials with negative controls. Vet. Clin. North Am. Food Anim. Pract. 31(1):
microbials in an attempt to match animal health
97–111. doi:10.1016/j.cvfa.2014.11.003.
risk with antimicrobial tier effectiveness and cost in
Dennis, E.J., T.C. Schroeder, D.G. Renter, and D.L. Pendell.
an effort to maximize profit.
2018. Value of arrival metaphylaxis in US cattle industry.
J. Agric. Resour. Econ. 43:1835.
ACKNOWLEDGMENTS
Irsik, M., M. Langemeier, T.C. Schroeder, M. Spire, and
J.D. Roder. 2006. Estimating the effects of animal
This project was supported with the folhealth on the performance of feedlot cattle. Bov. Pract.
lowing extra-institutional funding: Agriculture
40(2):65.
and Food Research Initiative Competitive Grant
Ives, S.E and J.T. Richeson. 2015. Use of antimicrobial metaphylaxis for the control of bovine respiratory disease in
number 2015-67015-23079 from the USDA
high-risk cattle. Vet. Clin. North Am. Food Anim. Pract.
National Institute of Food and Agriculture and
31(3):341–350. doi:10.1016/j.cvfa.2015.05.008.
by USDA Economic Research Service Cooperative
Mader, T.L., L.J. Johnson, and J.B. Gaughan. 2010. A comAgreement number 58-6000-6-0047. We have perprehensive index for assessing environmental stress in
formed consulting or sponsored research for the
animals. J. Anim. Sci. 88(6):2153–2165. doi:10.2527/
jas.2009-2586.
following companies: Bayer Animal Health, Beef
Miller, G.Y., X. Liu, P.E. McNamara, and E.J. Bush. 2005.
Improvement Federation, Boehringer Ingelheim
Farm-level impacts of banning growth-promoting antiVetmedica, Canadian Cattlemen’s Association,
biotic use in US pig grower/finisher operations. J. Agric.
CanFax, Cattlemen’s Beef Board, CME Group,
Bus. 23:345.
CoBank, Elanco Animal Health, Farm Credit
Nickell, J.S. and B.J. White. 2010. Metaphylactic antimicroServices of America, Merck Animal Health,
bial therapy for bovine respiratory disease in stocker and
feedlot cattle. Vet. Clin. North Am. Food Anim. Pract.
Monsanto, National Cattlemen’s Beef Association,
26(2):285–301. doi:10.1016/j.cvfa.2010.04.006.
National Pork Board, National Pork Producers
Nor, N.M., W. Steeneveld, M.C.M. Mourits, and H. Hogeveen.
Council, Novartis Animal Health, Progressive
2012. Estimating the costs of rearing young dairy cattle in
Beef, USDA, and Zoetis Animal Health. No
the Netherlands using a simulation model that accounts
pharmaceutical companies were involved in design,
for uncertainty related to diseases. Prev. Vet. Med. 106(3–
4):214–224. doi:10.1016/j.prevetmed.2012.03.004.
research, analysis, or manuscript preparation nor
O’Connor,
A.M, J.F. Coetzee, N. da Silva, and C. Wang. 2013.
provided financial support.
A mixed treatment comparison meta-analysis of antibiConflict of interest statement. None declared.
otic treatments for bovine respiratory disease. Prev. Vet.
Med. 110(2):77–87. doi:10.1016/j.prevetmed.2012.11.025.
Smith, A.B., D. G. Renter, N. Cernicchiaro, X. Shi, J. S. Nickell,
LITERATURE CITED
D. J. Keil, and T.G. Nagaraja. 2017. A randomized
Abell, K. M, M.E. Theurer, R.L. Larson, B.J. White,
trial to assess the effect of fluoroquinolone metaphyand M. Apley. 2017. A mixed treatment comparison
laxis on the fecal prevalence and quinolone susceptibilimeta-analysis of metaphylaxis treatments for bovine
ties of Salmonella and Campylobacter in feedlot cattle.
respiratory disease in beef cattle. J. Anim. Sci. 95(2):
Foodborne Pathog. Dis. 14(10):600–607. doi: 10.1089/
626–635. doi:10.2527/jas2016.1062.
fpd.2017.2282.
Babcock, A. 2010. Epidemiology of bovine respiratory
Tennant, T.C., S.E. Ives, L.B. Harper, D.G. Renter, and
Translate basic science to industry innovation

1102

Dennis et al.

T.E. Lawrence. 2014. Comparison of tulathromycin and
tilmicosin on the prevalence and severity of bovine respiratory disease in feedlot cattle in association with feedlot performance, carcass characteristics, and economic
factors. J. Anim. Sci. 92(11):5203–5213. doi: 10.2527/
jas.2014-7814.
Theurer, M.E., B.J. White, R.L. Larson, and T.C. Schroeder.
2015. A stochastic model to determine the economic value
of changing diagnostic test characteristics for identification of cattle for treatment of bovine respiratory disease.
J. Anim. Sci. 93(3):1398–1410. doi:10.2527/jas.2014-8487.
APHIS. 2013. USDA. Feedlot 2011 Part IV: Health and
Health Management on U.S. Feedlots with a Capacity of

1,000 or More Head. Fort Collins (CO): National Health
Monitoring System; p. 1–95.
United States Department of Agriculture. 2019. Antimicrobial
Use and Stewardship on U.S. Feedlots, 2017.
Van der Fels-Klerx, H.J., J.T. Sørensen, A.W. Jalvingh, and
R.B.M. Huirne. 2001. An economic model to calculate
farm-specific losses due to bovine respiratory disease in
dairy heifers. Prev. Vet. Med. 51(1–2):75–94. doi:10.1016/
S0167-5877(01)00208-2.
Wang, M., L.G. Schneider, K.J. Hubbard, and D.R. Smith. 2018.
Cost of bovine respiratory disease in pre-weaned calves
on US beef cow–calf operations (2011–2015). J. Am. Vet.
Med. Assoc. 253(5):624–631. doi:10.2460/javma.253.5.624.

Translate basic science to industry innovation

